VERU MEXC RealStocks
Own real VERU shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1
Last updated: 2026-11-14 13:54:00. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Veru Inc. (VERU) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $2.10, with a market capitalization of $36.15M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $2.04 to $7.33. This page covers its latest market performance, valuation, price trends and company information.
$36.15M | |
$2.15 | |
$2.15 | |
$2.08 | |
$2.12 | |
86.80K | |
185.42K | |
-- | |
$7.33 | |
$2.04 | |
-- | |
-- |
Veru Inc. (VERU) last closed at $2.10 as of 2026-11-14 00:57:00, down 1.42% ($0.03) from the previous close of $2.12.
During the latest regular trading session, VERU traded between $2.08 and $2.15, with a volume of 86.80K shares. The closing price was near the lower end and near the lower end of its 52-week range.
Over the past seven days, Veru Inc. (VERU) moved from $2.06 to $2.10, representing a gain of 2.09% ($0.04).
The stock traded between $2.04 and $2.21 during the period. The latest price is near the middle of the 7-day range, indicating moderate upward.
The average daily volume was 119.63 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 1.2%
VERU is currently trading at $2.10, placing it 1.2% of the way from its 52-week low of $2.04 to its 52-week high of $7.33. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Veru Inc is a late clinical-stage biopharmaceutical focused on developing medicines for the treatment of cardiometabolic and inflammatory diseases. Its drug development program consists of two late-stage new chemical entities, enobosarm and sabizabulin. Enobosarm, an oral selective androgen receptor modulator, is being developed to make weight reduction by GLP-1 RA drugs more tissue selective for loss of fat and preservation of lean mass, and is planned for a Phase 2b PLATEAU clinical study in obesity. Sabizabulin, an oral microtubule disruptor, is being developed for the treatment of inflammation in atherosclerotic cardiovascular disease to lower high-sensitivity CRP in patients with stable coronary artery disease, with a planned Phase 2 study.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 20 |
| Exchange | NASDAQ |
| Company Website |
View the latest dividend and stock split events for Veru Inc.
Dividend | |
|---|---|
| Ex-Dividend Date | Apr 28, 2014 |
| Payment Date | May 7, 2014 |
| Dividend Per Share | $0.07 |
Eligible investors can buy real shares of Veru Inc. (VERU) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to VERU, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between VERU shares and USD.
VERU Shares to USD
1.00 VERU shares = 2.103 USD
Calculations are estimates based on the latest available price and are for reference only.